Fear of cancer recurrence and quality of life among gynaecological cancer survivors under treatment

2021 ◽  
Vol 31 ◽  
pp. S276-S280
Author(s):  
Ni Kadek Puspitasari Ayu ◽  
Yati Afiyanti
2021 ◽  
Author(s):  
Jinyoung Shin ◽  
Dong Wook Shin ◽  
Jungkwon Lee ◽  
JiHye Hwang ◽  
Ji Eun Lee ◽  
...  

Abstract Background: This study aimed to evaluate factors related to the fear of cancer recurrence (FCR) in stomach cancer survivors.Methods: A total of 363 stomach cancer survivors were divided into three groups according to the Korean version of the FCR Index (FCRI). We compared the socio-demographic and cancer-related factors, communication within the medical team during treatment, care coordination, social support, physical symptoms, psychological distress, and health-related quality of life (HRQoL), and health promotion and disease prevention activity, which was defined as second primary cancer screening, osteoporosis evaluation, supplementary drug intake, dietary pattern, regular exercise, and smoking cessation, according to the levels of FCRI using the linear regression analysis after adjusting for age, sex, stage, time since diagnosis, family cancer diagnosis, and comorbidities.Results: An average of 7.3 years have passed since diagnosis. The highest FCRI group was younger or had a high percentage of family cancer diagnosis. Satisfaction for communication and care coordination, social support, HRQoL, and physical symptoms, such as fatigue, pain, and insomnia, were negatively associated with the FCR of stomach cancer survivors. Anxiety and depression were positively associated with the FCR. However, FCR was not associated with sex, time since diagnosis, cancer stage, treatment modality, socioeconomic status, or health promotion and disease prevention activity.Conclusions: FCR in stomach cancer survivors was associated with physical, psychological, and HRQoL factors rather than socio-demographic or cancer–related factors. Understanding the association between HRQoL, physical and psychosocial factors, and FCR may advance survivorship care for stomach cancer survivors.


Endoscopy ◽  
2010 ◽  
Vol 42 (07) ◽  
pp. 525-531 ◽  
Author(s):  
W. Rosmolen ◽  
K. Boer ◽  
R. de Leeuw ◽  
C. Gamel ◽  
M. van Berge Henegouwen ◽  
...  

2020 ◽  
Vol 3 ◽  
Author(s):  
Christine Shepler ◽  
Elizabeth Cottingham ◽  
Patrick Stutz ◽  
Shelley Johns

Background: Fear of cancer recurrence (FCR) takes an emotional toll on cancer survivors and significantly undermines quality of life following treatment. During a randomized controlled trial of Acceptance and Commitment Therapy (ACT) for post-treatment breast cancer survivors with clinically significant FCR, we conducted qualitative interviews to glean a deeper understanding of the impact of ACT on survivors’ coping with FCR.  Methods: Breast cancer survivors (stage I-III) who had completed a 6-week ACT intervention were invited to share their experiences in semi-structured qualitative interviews. Interviews were transcribed verbatim and analyzed thematically using a deductive approach. Participants received a $25 gift card for their time. Participants (n=16) were primarily White (81.3%) and college educated (68.8%), with a mean age of 57.3 (SD=11.1) and 75% had an income over $50,000.    Results: Prior to the study, survivors generally coped with FCR by denying their FCR or by attempting to control their fears through faith, lifestyle management, avoidance, and positivity. Survivors uniformly noted the sense of community they felt in their ACT group when listening to other survivors describe their own struggle with FCR. This common bond created a foundation that allowed survivors to embrace the ACT intervention and develop adaptive coping skills related to acceptance, present-moment awareness, and living consistently with one’s values. Survivors noted that these skills reduced the negative impact of FCR and other life challenges and improved quality of life compared to pre-study coping techniques.  Conclusion and Potential Impact: By building trust with other cancer survivors, participants were able to shift from attempts to ‘control’ FCR to a more ‘accepting’ approach to manage FCR and other life stressors. While research with a larger group of participants is needed, initial findings indicate that ACT may be a promising addition to care for cancer survivors. 


2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 289-289 ◽  
Author(s):  
Maria Q. B. Petzel ◽  
Nathan H Parker ◽  
Alan D. Valentine ◽  
Sebastien Simard ◽  
Graciela M Nogueras Gonzalez ◽  
...  

289 Background: Fear of Cancer Recurrence (FCR) is well documented among survivors of breast, colon and prostate cancer. Incurable recurrence is common following resection of pancreatic and periampullary neoplasms. The incidence and significance of FCR in this population is unknown. We hypothesized that FCR represents an important source of psychosocial distress following resection of pancreatic neoplasms. Methods: We conducted a cross-sectional study of patients with non-recurrent pancreatic ductal (PDAC), periampullary adenocarcinoma or pancreatic neuroendocrine tumor (PNET) treated with potentially curative surgery 1991–2011. We assessed 7 discrete dimensions of FCR using the Fear of Recurrence Inventory (FCRI) and evaluated quality of life (QOL) and psychosocial distress using the Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire and Hospital Anxiety and Depression Scale. Participants completed these validated instruments by mail. Results: 188 (53%) of 355 eligible patients completed at least one instrument, a median of 49 months (range, 6–222 months) following potentially curative resection. Participants included 73 (39%) patients with PDAC, 55 (29%) with periampullary adenocarcinoma, and 60 (32%) with PNET. The median FCR severity score was higher than a previously established cutoff for clinical significance in 55%, 51% and 63% of patients with PDAC, periampullary adenocarcinoma and PNET, respectively. Older age, male gender, periampullary adenocarcinoma, negative lymph nodes, and longer interval since operation were clinical factors associated with lower total FCR score (all p<0.05). In multivariate analysis, only age (p=0.01) and gender (p=0.03) were independently associated with severity of FCR. A higher total FCR score was significantly associated with higher anxiety (r=0.64), depression (r=0.41) and lower QOL (r =−0.53), all p<0.001. Conclusions: Fear of cancer recurrence is pervasive following resection of pancreatic neoplasms, regardless of survivors’ histopathologic diagnosis, disease severity, or time since resection. Given its association with anxiety, depression and lower QOL, FCR represents a critical therapeutic target.


2019 ◽  
Vol 89 (3) ◽  
pp. 533-544 ◽  
Author(s):  
Hao Dang ◽  
Wouter H. de Vos tot Nederveen Cappel ◽  
Sarita M.S. van der Zwaan ◽  
M. Elske van den Akker-van Marle ◽  
Henderik L. van Westreenen ◽  
...  

2019 ◽  
Vol 41 (10) ◽  
pp. 1385-1406 ◽  
Author(s):  
Anne M. Reb ◽  
Diane G. Cope

Gynecologic cancer survivors experience significant distress that can impact quality of life (QOL). Optimal survivorship care requires an understanding of the survivor’s QOL and supportive care needs. The purpose of this study was to describe the QOL and needs of gynecologic cancer survivors. Women with an initial diagnosis of gynecologic cancer within 7 months of completing primary treatment ( N = 34) completed the QOL-Cancer Survivor tool and the Cancer Survivors’ Unmet Needs Survey. Fear of cancer recurrence was a repetitive theme for both tools. The lowest ranking QOL items were distress from diagnosis and treatment, family distress, and uncertainty about the future. Commonly reported needs included help to reduce stress, manage side effects, cope with fears of cancer recurrence, and gain reassurance that providers were communicating, and providing the very best medical care. Appreciating QOL and needs can facilitate the development of support services specifically tailored to gynecologic survivors.


Sign in / Sign up

Export Citation Format

Share Document